<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://my.spacstar.com/spac-ipo-news/attovia-therapeutics-reports-q2-2026-financial-results/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-02T21:47:48Z</news:publication_date>
      <news:title>Attovia Therapeutics Reports Q2 2026 Financial Results</news:title>
      <news:keywords>Attovia Therapeutics, ATTO, Q2 2026 earnings, biotech IPO, ATTO-1310</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://my.spacstar.com/spac-ipo-news/inflection-point-acquisition-corp-viii-closes-287-5m-ipo/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-02T20:47:28Z</news:publication_date>
      <news:title>Inflection Point Acquisition Corp. VIII Closes $287.5M IPO</news:title>
      <news:keywords>IPO, SPAC, IPHXU, Inflection Point Acquisition, Nasdaq</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://my.spacstar.com/spac-ipo-news/netskope-q2-2027-financial-results-exceed-guidance/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-02T20:27:20Z</news:publication_date>
      <news:title>Netskope Q2 2027 Financial Results Exceed Guidance</news:title>
      <news:keywords>Netskope, earnings, ARR, revenue, SASE</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://my.spacstar.com/spac-ipo-news/scribe-therapeutics-reports-q2-2026-results-and-ipo/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-02T20:16:44Z</news:publication_date>
      <news:title>Scribe Therapeutics Reports Q2 2026 Results and IPO</news:title>
      <news:keywords>Scribe Therapeutics, SCTX, earnings, IPO, biotechnology</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://my.spacstar.com/spac-ipo-news/advasa-adds-usdc-payment-functionality-to-advasa-visa-card/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-02T13:19:35Z</news:publication_date>
      <news:title>Advasa Adds USDC Payment Functionality to ADVASA Visa Card</news:title>
      <news:keywords>USDC, Visa card, fintech, crypto payments, Advasa</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://my.spacstar.com/spac-ipo-news/first-breach-expands-ammunition-capacity-to-20m-rounds/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T21:12:54Z</news:publication_date>
      <news:title>First Breach Expands Ammunition Capacity to 20M Rounds</news:title>
      <news:keywords>First Breach, ammunition, manufacturing, capacity, defense technology</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://my.spacstar.com/spac-ipo-news/jones-ventures-intl-announces-separate-trading-for-shares/</loc>
    <news:news>
      <news:publication>
        <news:name>SPACSTAR</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T20:25:34Z</news:publication_date>
      <news:title>Jones Ventures INTL Announces Separate Trading for Shares</news:title>
      <news:keywords>JONE, JONEU, JONER, SPAC, IPO</news:keywords>
    </news:news>
  </url>
</urlset>
